Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05074472
Title A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ZielBio, Inc.
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic - Phoenix Phoenix Arizona 85054 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
Mayo Clinic - Rochester Rochester Minnesota 55905 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
NEXT Oncology Austin Texas 78758 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
University of Virginia Charlottesville Virginia 22908 United States Details
NEXT Onoology Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from for the field